Who owns NEKTAR THERAPEUTICS?

Tip: Access positions for across all investors

Analyze quarterly positions in Nektar Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Nektar Therapeutics stock

Who bought or sold NEKTAR THERAPEUTICS this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Group One Trading 120k $6.8M -32% Sep 2025
 View chart
Simplex Trading 69k $3.9M -49% Sep 2025
 View chart
Hrt Financial 12k $705k 100% Sep 2025
 View chart

Who sold out of Nektar Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Exome Asset Management Jun 2025 75k $1.9M
Velan Capital Investment Management Jun 2025 50k $1.3M